Saudi Arabia's new GRADE-based playbook for treating moderate-to-severe IBD.
Mahmoud H. Mosli, Badr Al-Bawardy, Turki AlAmeel, et al.
This Saudi national guideline, developed by a 16-expert GRADE panel answering 41 clinical questions, sets out 38 recommendations and two good-practice statements for treating adults with moderate-to-severe Crohn's disease and ulcerative colitis. It covers induction and maintenance with advanced therapies, when to combine treatments, optimization strategies, and special clinical situations. The panel notes that more local real-world data are still needed to refine these recommendations over time.
- The question: How should clinicians in Saudi Arabia treat adults with moderate-to-severe Crohn's disease and ulcerative colitis?
- The study: A national panel of 16 experts used the GRADE approach to answer 41 clinical questions on medical management.
- The finding: The result is 38 recommendations and two good-practice statements, covering induction and maintenance with advanced therapies.
- The nuance: They also address when to combine treatments, how to optimize therapy, and how to handle special clinical situations.
Takeaway: a national, evidence-graded roadmap for advanced IBD therapy, though more local real-world data are still needed to refine it.
Narrated (standard AI voice, not a cloned voice) with burned-in captions matching the narration word-for-word — safe to watch muted. Built from this article’s SGA Briefing only.
This links to the publisher’s open-access copy of record. A self-hosted PDF will appear here once one is on file.